NO20063991L - Fremgangsmate for fremstilling av substituerte triazolforbindelser - Google Patents
Fremgangsmate for fremstilling av substituerte triazolforbindelserInfo
- Publication number
- NO20063991L NO20063991L NO20063991A NO20063991A NO20063991L NO 20063991 L NO20063991 L NO 20063991L NO 20063991 A NO20063991 A NO 20063991A NO 20063991 A NO20063991 A NO 20063991A NO 20063991 L NO20063991 L NO 20063991L
- Authority
- NO
- Norway
- Prior art keywords
- triazole compounds
- preparation
- substituted triazole
- substituted
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D249/14—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US54372104P | 2004-02-11 | 2004-02-11 | |
| US62368104P | 2004-10-29 | 2004-10-29 | |
| PCT/US2005/001917 WO2005077922A2 (en) | 2004-02-11 | 2005-01-21 | Process for the preparation of substituted triazole compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20063991L true NO20063991L (no) | 2006-11-08 |
Family
ID=34864531
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20063991A NO20063991L (no) | 2004-02-11 | 2006-09-06 | Fremgangsmate for fremstilling av substituerte triazolforbindelser |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20060100259A1 (es) |
| EP (1) | EP1720843A2 (es) |
| JP (1) | JP2007522213A (es) |
| KR (1) | KR20070036025A (es) |
| AR (1) | AR047544A1 (es) |
| AU (1) | AU2005212218A1 (es) |
| BR (1) | BRPI0507634A (es) |
| CA (1) | CA2555825A1 (es) |
| CR (1) | CR8562A (es) |
| EA (1) | EA200601441A1 (es) |
| EC (1) | ECSP066768A (es) |
| IL (1) | IL177315A0 (es) |
| MX (1) | MXPA06009193A (es) |
| NO (1) | NO20063991L (es) |
| TW (1) | TW200538116A (es) |
| WO (1) | WO2005077922A2 (es) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1797049A4 (en) * | 2004-10-08 | 2009-06-17 | Janssen Pharmaceutica Nv | 1,2,4-TRIAZOLYLAMINOARYL (HETEROARYL) SULFONAMIDE DERIVATIVES |
| EP1922310A2 (en) | 2005-09-07 | 2008-05-21 | Rigel Pharmaceuticals, Inc. | Triazole derivatives useful as axl inhibitors |
| WO2008083356A1 (en) | 2006-12-29 | 2008-07-10 | Rigel Pharmaceuticals, Inc. | Substituted triazoles useful as axl inhibitors |
| PT2078010E (pt) | 2006-12-29 | 2014-05-07 | Rigel Pharmaceuticals Inc | Triazoles substituídos com heteroarilos policíclicos úteis como inibidores de axl |
| WO2008083353A1 (en) | 2006-12-29 | 2008-07-10 | Rigel Pharmaceuticals, Inc. | Bicyclic aryl and bicyclic heteroaryl substituted triazoles useful as axl inhibitors |
| EP2074115B1 (en) | 2006-12-29 | 2018-03-07 | Rigel Pharmaceuticals, Inc. | N3-heteroaryl substituted triazoles and n5-heteroaryl substituted triazoles useful as axl inhibitors |
| ES2404668T3 (es) | 2006-12-29 | 2013-05-28 | Rigel Pharmaceuticals, Inc. | Triazoles sustituidos con arilo bicíclico puenteado y heteroarilo bicíclico puenteado, útiles como agentes inhibidores del axl |
| WO2009054864A1 (en) | 2007-10-26 | 2009-04-30 | Rigel Pharmaceuticals, Inc. | Polycyclic aryl substituted triazoles and polycyclic heteroaryl substituted triazoles useful as axl inhibitors |
| PT2328888E (pt) | 2008-07-09 | 2013-01-29 | Rigel Pharmaceuticals Inc | Triazóis bicíclicos em ponte substituídos com heteroarilos úteis como inibidores axl |
| JP5592884B2 (ja) | 2008-07-09 | 2014-09-17 | ライジェル ファーマシューティカルズ， インコーポレイテッド | Ａｘｌ阻害剤として有用な多環式ヘテロアリール置換トリアゾール |
| PT2387395E (pt) | 2009-01-16 | 2015-02-04 | Rigel Pharmaceuticals Inc | Inibidores de axl para utilização em terapia de combinação para prevenir, tratar ou gerir cancro metastático |
| US20140010783A1 (en) * | 2012-07-06 | 2014-01-09 | Hoffmann-La Roche Inc. | Antiviral compounds |
| CN116003336A (zh) * | 2023-01-09 | 2023-04-25 | 赣南师范大学 | 一种1,2,4-三氮唑-3-胺类化合物及其制备方法和应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2274639C2 (ru) * | 2000-12-22 | 2006-04-20 | Орто-Макнейл Фармасьютикал, Инк. | Производные замещенного триазолдиамина, фармацевтическая композиция на их основе и способ ее получения |
| CL2003002353A1 (es) * | 2002-11-15 | 2005-02-04 | Vertex Pharma | Compuestos derivados de diaminotriazoles, inhibidores d ela proteina quinasa; composicion farmaceutica; procedimiento de preparacion; y su uso del compuesto en el tratamiento de enfermedades de desordenes alergicos, proliferacion, autoinmunes, condic |
-
2005
- 2005-01-21 JP JP2006553136A patent/JP2007522213A/ja not_active Withdrawn
- 2005-01-21 KR KR1020067018359A patent/KR20070036025A/ko not_active Application Discontinuation
- 2005-01-21 WO PCT/US2005/001917 patent/WO2005077922A2/en active Application Filing
- 2005-01-21 BR BRPI0507634-0A patent/BRPI0507634A/pt not_active Application Discontinuation
- 2005-01-21 EA EA200601441A patent/EA200601441A1/ru unknown
- 2005-01-21 EP EP05711766A patent/EP1720843A2/en not_active Withdrawn
- 2005-01-21 AU AU2005212218A patent/AU2005212218A1/en not_active Abandoned
- 2005-01-21 MX MXPA06009193A patent/MXPA06009193A/es unknown
- 2005-01-21 CA CA002555825A patent/CA2555825A1/en not_active Abandoned
- 2005-01-21 US US11/040,757 patent/US20060100259A1/en not_active Abandoned
- 2005-02-03 TW TW094103283A patent/TW200538116A/zh unknown
- 2005-02-10 AR ARP050100485A patent/AR047544A1/es unknown
-
2006
- 2006-08-06 IL IL177315A patent/IL177315A0/en unknown
- 2006-08-10 EC EC2006006768A patent/ECSP066768A/es unknown
- 2006-08-14 CR CR8562A patent/CR8562A/es not_active Application Discontinuation
- 2006-09-06 NO NO20063991A patent/NO20063991L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| MXPA06009193A (es) | 2007-01-26 |
| US20060100259A1 (en) | 2006-05-11 |
| IL177315A0 (en) | 2006-12-10 |
| EP1720843A2 (en) | 2006-11-15 |
| CA2555825A1 (en) | 2005-08-25 |
| TW200538116A (en) | 2005-12-01 |
| KR20070036025A (ko) | 2007-04-02 |
| AU2005212218A1 (en) | 2005-08-25 |
| ECSP066768A (es) | 2006-11-16 |
| BRPI0507634A (pt) | 2007-07-03 |
| WO2005077922A2 (en) | 2005-08-25 |
| JP2007522213A (ja) | 2007-08-09 |
| CR8562A (es) | 2008-09-09 |
| WO2005077922A3 (en) | 2006-01-26 |
| EA200601441A1 (ru) | 2007-02-27 |
| AR047544A1 (es) | 2006-01-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20063991L (no) | Fremgangsmate for fremstilling av substituerte triazolforbindelser | |
| NO20083918L (no) | Dihydridiazepiner anvendelige som inhibitorer av proteinkinaser | |
| NO20084747L (no) | Tetrahydropteridiner anvendbare som inhibitorer av protein kinaser | |
| WO2005072706A3 (en) | Nanosuspensions of anti-retroviral agents for increased central nervous system delivery | |
| WO2009006389A3 (en) | Pyrimidine derivatives useful as raf kinase inhibitors | |
| NO20072092L (no) | Sulfonamidforbindelser | |
| ATE427965T1 (de) | Antikírper gegen 25-hydroxyvitamin d | |
| NO20071619L (no) | Fremgangsmate for fremstilling av indazol forbindelse | |
| WO2007117995A3 (en) | Kinase inhibitors | |
| WO2007027238A3 (en) | Jak kinase inhibitors and their uses | |
| NO2012017I1 (no) | Benzimidazolderivat, fremgangsmåte for fremstilling derav, medikament inneholdende denne forbindelsen samt anvendelse av forbindelsen. | |
| WO2013010136A3 (en) | Inhibitors of bruton's tyrosine kinase | |
| NO20070933L (no) | Indazoler anvendbare i behandling av kardiovaskulaere sykdommer | |
| NO20085029L (no) | Substituerte pyridylamidforbindelser som modulatorer av histamin H3 reseptoren | |
| NO20085373L (no) | P38 inhibitorer, deres fremstilling og anvendelse | |
| TW200801008A (en) | Protein kinase inhibitors | |
| AU2009270856A8 (en) | Inhibitors of Bruton's tyrosine kinase for the treatment of solid tumors | |
| TW200604184A (en) | Processes and intermediates useful for preparing fused heterocyclic kinase inhibitors | |
| NO20080675L (no) | P38-Map kinaseinhibitorer og metoder for deres anvendelse | |
| MY146989A (en) | Kinase inhibitors | |
| CL2007002384A1 (es) | Uso de compuestos derivados de 2,5-dihidroxibenceno para el tratamiento de la psoriasis. | |
| NO20070188L (no) | Krystallisert polyetylentereftalat som inneholder silisium og fremgangsmate for fremstilling derav | |
| NO20092603L (no) | Apparat for fremstilling av et stabilt oksiderende biocid | |
| BR112021020508A2 (pt) | Inibidor de jak de 7h-pirrolo[2,3-d]pirimidina | |
| WO2007014250A8 (en) | Abl kinase inhibition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |